Evotec, Novo Nordisk Roll Out LAB EN To Accelerate Translation In Cardiometabolic Diseases
(RTTNews) - Evotec SE (EVO, EVOTF.PK) and Novo Nordisk A/S (NVO) announced Tuesday a translational drug discovery accelerator called LAB eN, which aims to nurture early research from academic institutions into novel therapeutics.
LAB eN is a unique engagement model that combines Evotec's multimodality drug discovery and pre-clinical development capabilities with Novo Nordisk's therapeutic, clinical, and commercial expertise.
LAB eN will focus on addressing unmet need in cardiometabolic diseases as well as rare blood and rare endocrine disorders.
LAB eN has already signed on four academic institutions to participate: Harvard University, Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center.
read more
Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply
Danish drug maker Novo Nordisk announced its plans to invest $4.1 billion or about 27 billion Danish kroner to build a new manufacturing plant in Clayton, North Carolina with a view to expanding its manufacturing capacity in the United States. In the new plant, the company plans to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
RTTNews
|
95 days ago
Novo Nordisk Says FLOW Trial Achieves Primary Endpoint
Novo Nordisk A/S (NVO) announced Tuesday the headline results from the kidney outcomes trial FLOW. The announcement follows the decision to stop the trial early due to efficacy.
RTTNews
|
207 days ago
Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%
Healthcare company Novo Nordisk Inc. (NVO) announced Tuesday it is lowering the U.S. list prices of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.
RTTNews
|
564 days ago
U.S. Dollar Moves Modestly Lower Following Inflation Data
The value of the U.S. dollar index has moved modestly lower over the course of trading on Friday, as traders react to closely watched inflation data.
RTTNews
|
1 day ago
Swiss Market Ends Slightly Higher
The Switzerland market shrugged off early weakness and moved modestly higher on Friday, tracking positive global cues. Investors continued to cheer Swiss National Bank's interest rate move, in addition to digesting U.S. personal consumption expenditure data.
RTTNews
|
1 day ago
European Stocks Close Week On A Firm Note
European stocks closed higher on Friday, with several major markets hitting record highs, as investors continued to cheer China's stimulus announcements, and bet on hopes of more interest-rate cuts by central banks.
RTTNews
|
1 day ago
U.S. Dollar Falls As Soft PCE Inflation Data Supports Rate Cut Hopes
The U.S. dollar weakened against its major counterparts in the New York session on Friday, as PCE inflation cooled in August, raising the possibility of a 50 basis point rate cut by the Federal Reserve in November.
RTTNews
|
1 day ago
Canadian Market Up Marginally In Cautious Trade
The Canadian market is up marginally on Friday with stocks turning in a mixed performance in cautious trade. Investors are digesting the latest batch of Canadian economic data, and reports on U.S. consumption expenditure, personal income & spending.
RTTNews
|
1 day ago
